Home / Denmark / Zealand Pharma A/S
Zealand Pharma A/S
Short position disclosed on May 29, 2026.
6.75% of the capital sold short
8 disclosing funds
454 disclosures on record
DK0060257814 ISIN code
Evolution of the disclosed total
0%2%4%6%8%
Oct 2025Jan 2026Apr 2026Jul 2026
March 31, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Marshall Wace LLP | 1.29% | new | May 26, 2026 | |
| Voleon Capital Management LP | 1.11% | new | May 19, 2026 | |
| AHL Partners LLP | 0.91% | new | May 7, 2026 | |
| Citadel Advisors LLC | 0.83% | new | May 29, 2026 | |
| Connor Clark & Lunn Investment Management Ltd | 0.80% | new | April 28, 2026 | |
| Jupiter Asset Management Limited | 0.70% | new | March 12, 2026 | |
| Jennison Associates LLC | 0.61% | new | April 13, 2026 | |
| D. E. Shaw & Co., L.P. | 0.50% | new | May 11, 2026 |
On the other side: the funds that hold Zealand Pharma A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 19, 2025 | Capital Fund Management | 0.68% | March 19, 2025 |
| March 18, 2025 | Canadian Pension Plan Investment Board | 0.50% | March 18, 2025 |
| March 14, 2025 | D. E. Shaw & Co., L.P. | 0.71% | March 14, 2025 |
| March 12, 2025 | D. E. Shaw & Co., L.P. | 0.64% | March 12, 2025 |
| March 4, 2025 | Capital Fund Management | 0.70% | March 4, 2025 |
| February 28, 2025 | AQR Capital Management, LLC | 0.50% | February 28, 2025 |
| February 18, 2025 | Capital Fund Management | 0.69% | February 18, 2025 |
| January 6, 2025 | Capital Fund Management | 0.71% | January 6, 2025 |
| December 20, 2024 | D. E. Shaw & Co., L.P. | 0.52% | December 20, 2024 |
| December 17, 2024 | AQR Capital Management, LLC | 0.49% | December 17, 2024 |
| December 6, 2024 | Qube Research & Technologies Ltd | 0.03% | December 6, 2024 |
| December 5, 2024 | Qube Research & Technologies Ltd | 0.80% | December 5, 2024 |
| December 5, 2024 | AQR Capital Management, LLC | 0.50% | December 5, 2024 |
| November 25, 2024 | Qube Research & Technologies Ltd | 0.74% | November 25, 2024 |
| November 22, 2024 | Qube Research & Technologies Ltd | 0.62% | November 22, 2024 |
| November 18, 2024 | Capital Fund Management | 0.62% | November 18, 2024 |
| November 13, 2024 | Capital Fund Management | 0.50% | November 13, 2024 |
| November 7, 2024 | Qube Research & Technologies Ltd | 0.55% | November 7, 2024 |
| November 6, 2024 | Qube Research & Technologies Ltd | 0.48% | November 6, 2024 |
| October 21, 2024 | Qube Research & Technologies Ltd | 0.51% | October 21, 2024 |
| October 17, 2024 | Qube Research & Technologies Ltd | 0.49% | October 17, 2024 |
| October 16, 2024 | Qube Research & Technologies Ltd | 0.51% | October 16, 2024 |
| October 11, 2024 | Qube Research & Technologies Ltd | 0.49% | October 11, 2024 |
| October 4, 2024 | Qube Research & Technologies Ltd | 0.55% | October 4, 2024 |
| September 25, 2024 | Qube Research & Technologies Ltd | 0.60% | September 25, 2024 |
| September 20, 2024 | Qube Research & Technologies Ltd | 0.52% | September 20, 2024 |
| July 9, 2024 | Arrowstreet Capital Limited Partnership | 0.61% | July 9, 2024 |
| July 1, 2024 | Arrowstreet Capital Limited Partnership | 0.57% | July 1, 2024 |
| June 5, 2024 | Arrowstreet Capital Limited Partnership | 0.61% | June 5, 2024 |
| June 4, 2024 | Arrowstreet Capital Limited Partnership | 0.51% | June 4, 2024 |
| June 3, 2024 | Arrowstreet Capital Limited Partnership | 0.61% | June 3, 2024 |
| May 23, 2024 | Arrowstreet Capital Limited Partnership | 0.51% | May 23, 2024 |
| May 7, 2024 | Capital Fund Management | 0.48% | May 7, 2024 |
| April 29, 2024 | Capital Fund Management | 0.52% | April 29, 2024 |
| August 23, 2023 | Perceptive Advisors LLC | 0.46% | August 23, 2023 |
| August 22, 2023 | Perceptive Advisors LLC | 0.72% | August 22, 2023 |
| August 21, 2023 | Perceptive Advisors LLC | 0.95% | August 21, 2023 |
| July 25, 2023 | Perceptive Advisors LLC | 1.01% | July 25, 2023 |
| July 21, 2023 | Perceptive Advisors LLC | 0.91% | July 21, 2023 |
| June 29, 2023 | Perceptive Advisors LLC | 0.81% | June 29, 2023 |
| June 28, 2023 | Perceptive Advisors LLC | 0.67% | June 28, 2023 |
| June 27, 2023 | Perceptive Advisors LLC | 0.54% | June 27, 2023 |
| April 21, 2023 | Armistice Capital, LLC | 0.49% | April 21, 2023 |
| April 5, 2023 | Voleon Capital Management LP | 0.45% | April 5, 2023 |
| April 4, 2023 | Voleon Capital Management LP | 0.50% | April 4, 2023 |
| April 3, 2023 | Armistice Capital, LLC | 0.50% | April 3, 2023 |
| February 27, 2023 | Armistice Capital, LLC | 0.49% | February 27, 2023 |
| February 17, 2023 | D. E. Shaw Investment Management, L.L.C. | 0.49% | February 17, 2023 |
| February 6, 2023 | Armistice Capital, LLC | 0.51% | February 6, 2023 |
| January 9, 2023 | Armistice Capital, LLC | 0.49% | January 9, 2023 |
Other companies sold short in Denmark
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Zealand Pharma A/S, source Finanstilsynet, data as at May 29, 2026, https://www.quivad.com/action/zealand-pharma-a-s?page=4